RSV causes a substantial burden worldwide. After over six decades of research, there is finally a licensed immunization option that can protect the broad infant population, and other will follow soon.

mRNA vaccines are being used to contain COVID-19, but still suffer from the critical limitation of mRNA instability and degradation, which is a major obstacle in the storage, distribution, and efficacy of the vaccine products.

European Immunization Week is marked across Europe every year in the final week of April. It aims to raise awareness of the importance of immunisation for the general health and well-being of the European and wider population.

Ahead of European Immunisation Week (EIW), taking place from 23 to 29 April 2023, Isabel de la Mata -principal advisor for Health and Crisis Management at the European Commission- talks about the benefits of lifelong vaccination

With the World Immunization Week coming up, IFA has produced a study to deliver critical baseline data to help inform technical guidelines, as well as governmental and civil society dialogue and policy actions, to protect the health of LTC residents.

It provides an overview of the project results at the end of 2 years of collaborative work: the training tools and resources designed to support health professionals in their vaccine communication efforts and the advocacy campaigns.

The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses and the development of new variant-derived vaccines.

H5N1 avian influenza viruses of the A/goose/Guangdong/1/96 lineage have been circulating in wild birds for many years, have inflicted significant economic losses on the poultry industry and have caused zoonotic infections since 1997.

What do Ebola, Dengue Fever, Lassa Fever, or other hemorrhagic fevers, that often inspire Hollywood productions, have in common with respiratory viruses, such as influenza or Sars-Cov2?

The global surge in the omicron (B.1.1.529) variant has resulted in many individuals with hybrid immunity (immunity developed through a combination of SARS-CoV-2 infection and vaccination).

This project was commissioned to collect evidence focused on specific life-course approach to immunization (LCI) policies and priority geographies, and to compare available data sets and case studies before and during the COVID-19 pandemic.

Members of the European Parliament looked at the possible consequences to children's well-being, including their mental health.